Live and Virtual
Friday, October 13, 2023
Hilton Union Square
333 O'Farrell Street
San Francisco, California, USA
ISAP 32nd Annual Meeting Program
0815–1800 Pacific Time Zone, USA
0815 – 0830 - ISAP Welcome/Announcements– Stuart Forman, MD
0830–1000 - Session 1 – Pharmacology
0830 – 0900
End-tidal anesthetic concentration: monitoring, interpretation, and clinical application.
Andre De Wolf, MD, Professor Emeritus, Northwestern University, Evanston, IL, USA
0900 – 0930
Gas Man® for Learning, Teaching, and Studying Inhalation Anesthesia Kinetic
James H. Philip, ME(E), MD, CCE, Anesthesiologist and Director of Clinical Bioengineering, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Medical Liaison for Anesthesia, Department of Biomedical Engineering, Partners HealthCare System, Professor of Anaesthesia, Harvard Medical School, Boston, MA, USA
0930 – 1000
Kalman Filtering in PKPD Modelling of Anaesthetic Drugs
Samaneh Nasiri, PhD, Harvard Medical School, Boston, MA, USA
1000-1015 - Break
1015 – 1045
Low Flow Anesthesia - 100 Years Later
Jeffrey Feldman, MD, MSE, Children’s Hospital of Philadelphia, University of Pennsylvania, PA, USA
1045 – 1115
Climate Impact of Volatile Anesthetics: Vital Insights for Anesthetists in the Era of Climate Change
Prof. Alain Kalmar, MD, PhD, Sint-Jan Hospital Brugge-Oostende, Belgium; Ghent University, Belgium
1115 – 1145
Action Guidance for Addressing Pollution from Inhalational Anaesthetics
Jodi Sherman, MD, Yale School of Medicine, New Haven, CT, USA
1145-1300 - Luncheon – ISAP Business Meeting
1300 – 1400 - Session 3 – Up and Coming Anesthetics & Research
Effects of Site Concentration Guided Anesthesia with Analysis on Protocols of Clinical Outcomes for The Patient
Pether K Jildenstål, PhD, Associate Professor PhD, Lund University, Lund, Sweden
Henrik Öhrström, MD, Department of Anaesthesiology and Intensive Care, Örebro Univeristy Hospital, Örebro, Sweden
1400 – 1445 - Mohamed Naguib Lecture
General Introduction on the Role of Pro-resolving Mediators (SPMs)
Charles N. Serhan, PhD, DSc, Gelman Professorship Harvard Medical School, Director Center for Experimental Therapeutics and Reperfusion Injury and Professor of Oral Medicine, Infection and Immunity, Brigham and Women's Hospital, Harvard University, Boston, MA, USA
1445-1500 - Break
1500– 1630 - Moderated Poster Session 90 minutes
1630-1645 - Break
1645 – 1730 - Keynote Speaker & Lifetime Achievement Awardee
Keynote: Anesthesia, the Eternal Loop Between Physiology and Pharmacology
Albert Dahan, MD, PhD, Full Professor of Anesthesiology, Head of Research, Head of the Anesthesia & Pain Research Unit, Staff Anesthesiologist, Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands
1730 – 1800 - Gathering
Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by Amedco LLCand International Society for Anaesthetic Pharmacology. Amedco LLC is jointly accredited by theAccreditation Council for Continuing Medical Education (ACCME), the Accreditation Council forPharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to providecontinuing education for the healthcare team.Physicians
ACCME Credit Designation Statement: Amedco LLC designates this live activity for a maximum of 5.50 AMA PRA Category 1 CreditsTM for physicians. Physiciansshould claim only the credit commensurate with the extent of their participation in the activity.
CME Objectives, Practice Gaps, Educational Needs
Program Target Audience: This program is designed for an international audience of general anesthesiologists and anesthesiologists with a special interest in clinical pharmacology and technology.
Objectives of the Program: After attending this program you should be able to:
- Effectively understand the delivery and monitoring of anesthetic agents.
- Recognize new methods of PKPD modeling including Kalman Filtering.
- Obtain insight into the effects of inhaled anesthetics on the environment.
- Explore methods of reducing the environmental impact of anesthetic agents.
- Appreciate new methods of anesthesia delivery including effect site concentration guided anesthesia and assess the clinical outcomes of these new methods.
- Learn about the role of pro-resolving mediators (SPMs) in anesthesiology.
- Recollect on the history of anesthesia and its melding of physiology and pharmacology.
• Anesthesiologists require information to understand, assess, and prevent the undesired effects of anesthetic drugs on the environment.
• Learning about monitoring and analytical techniques (such as effect-site concentration guidance, the role of proresolving mediators, and PKPD modelling techniques) help to expand therapeutic and research strategies.
• Understanding the delivery and monitoring of anesthetic delivery including the use of simulation helps to improve anesthetic practice.
• Providing unbiased assessment and education for clinicians.
• Provide insight into future possibilities for improved clinical performance in anesthetic drug titration.